{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:15:05Z","timestamp":1760890505248,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jpba.2022.115167","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T02:12:47Z","timestamp":1668996767000},"page":"115167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A liquid chromatography-tandem mass spectrometry method for the quantification of ampicillin\/sulbactam and clindamycin in jawbone, plasma, and platelet-rich fibrin: Application to patients with osteonecrosis of the jaw"],"prefix":"10.1016","volume":"224","author":[{"given":"Maximilian","family":"Stapf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Linz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Scherf-Clavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115167_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res"},{"issue":"5","key":"10.1016\/j.jpba.2022.115167_bib2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.jpba.2022.115167_bib3","unstructured":"Schiegnitz E.A.-N.B., Hoefert S., Otto S., Pautke C., Ristow O., Voss P., Gr\u00f6tz K.A.: S3 Leitlinie Antiresorptiva-assoziierte Kiefernekrosen (AR-ONJ). AWMF-Register-Nr. 007\u2013091. 2018. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/007\u2013091l_S3_Antiresorptiva-assoziierte-Kiefernekrosen-AR-ONJ_2018\u201312.pdf. Accessed 23 June 2022."},{"issue":"5","key":"10.1016\/j.jpba.2022.115167_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - a single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J. Craniomaxillofac Surg."},{"issue":"2","key":"10.1016\/j.jpba.2022.115167_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ID.0b013e3181752b09","article-title":"Prophylactic antibiotic regimens in oral implantology: rationale and protocol","volume":"17","author":"Resnik","year":"2008","journal-title":"Implant Dent."},{"issue":"3","key":"10.1016\/j.jpba.2022.115167_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.oooo.2017.11.022","article-title":"Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics. Oral Surg Oral Med Oral Pathol","volume":"125","author":"De Bruyn","year":"2018","journal-title":"Oral. Radio."},{"issue":"9","key":"10.1016\/j.jpba.2022.115167_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.joms.2006.05.023","article-title":"Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin","volume":"64","author":"Rega","year":"2006","journal-title":"J. Oral. Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.jpba.2022.115167_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1442-2050.2012.01328.x","article-title":"Bacterial flora of the human oral cavity, and the upper and lower esophagus","volume":"26","author":"Norder Grusell","year":"2013","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.jpba.2022.115167_bib9","unstructured":"Pfizer Pharma GmbH. (2022). Unacid: Prescribing Information. https:\/\/www.pfizer.de\/sites\/default\/files\/FI-2201.pdf. Accessed 23 June 2022."},{"key":"10.1016\/j.jpba.2022.115167_bib10","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Data from the EUCAST MIC distribution website, Accessed 23 June 2022. http:\/\/www.eucast.org."},{"issue":"1","key":"10.1016\/j.jpba.2022.115167_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.joms.2021.08.147","article-title":"Is penicillin allergy a risk factor for surgical site infection after oral and maxillofacial surgery?","volume":"80","author":"Roistacher","year":"2022","journal-title":"J. Oral. Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.jpba.2022.115167_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.coph.2007.05.003","article-title":"Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?","volume":"7","author":"Theuretzbacher","year":"2007","journal-title":"Curr. Opin. Pharm."},{"issue":"2","key":"10.1016\/j.jpba.2022.115167_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin. Pharm."},{"issue":"6","key":"10.1016\/j.jpba.2022.115167_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jpba.2022.115167_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore","volume":"44","author":"Ambrose","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2022.115167_bib16","unstructured":"World Health Organization. Antimicrobial resistance. 17 Nov 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed 31 May 2022."},{"issue":"1","key":"10.1016\/j.jpba.2022.115167_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41467-018-04059-1","article-title":"Evolution of high-level resistance during low-level antibiotic exposure","volume":"9","author":"Wistrand-Yuen","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jpba.2022.115167_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2013.10.021","article-title":"Prolonging beta-lactam infusion: a review of the rationale and evidence, and guidance for implementation","volume":"43","author":"MacVane","year":"2014","journal-title":"Int J. Antimicrob. Agents"},{"issue":"5","key":"10.1016\/j.jpba.2022.115167_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral. Radio."},{"issue":"6","key":"10.1016\/j.jpba.2022.115167_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00784-017-2133-z","article-title":"Use of platelet-rich fibrin in regenerative dentistry: a systematic review","volume":"21","author":"Miron","year":"2017","journal-title":"Clin. Oral. Invest."},{"issue":"5","key":"10.1016\/j.jpba.2022.115167_bib21","first-page":"7922","article-title":"Platelet-rich fibrin application in dentistry: a literature review","volume":"8","author":"Borie","year":"2015","journal-title":"Int J. Clin. Exp. Med"},{"issue":"6","key":"10.1016\/j.jpba.2022.115167_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1563\/aaid-joi-D-14-00138","article-title":"Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells","volume":"40","author":"Ghanaati","year":"2014","journal-title":"J. Oral. Implant."},{"issue":"1","key":"10.1016\/j.jpba.2022.115167_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01540-17","article-title":"Development of a novel multipenicillin assay and assessment of the impact of analyte degradation: lessons for scavenged sampling in antimicrobial pharmacokinetic study design","volume":"62","author":"Kipper","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2022.115167_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/0924-8579(95)00058-5","article-title":"Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin","volume":"6","author":"Wildfeuer","year":"1996","journal-title":"Int J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2022.115167_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00784-022-04663-y","article-title":"Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin\/sulbactam","author":"Straub","year":"2022","journal-title":"Clin. Oral. Invest."},{"issue":"3","key":"10.1016\/j.jpba.2022.115167_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tripleo.2010.05.048","article-title":"How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box","volume":"110","author":"Dohan Ehrenfest","year":"2010","journal-title":"Oral. Surg. Oral. Med Oral. Pathol. Oral. Radio. Endod."},{"key":"10.1016\/j.jpba.2022.115167_bib27","unstructured":"European Medicines Agency (EMA). European medicines agency guideline on bioanalytical method validation(EMEA\/CHMP\/EWP\/192217\/2009 Rev. 1 Corr. 2**). 2011. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed 31 May 2022."},{"key":"10.1016\/j.jpba.2022.115167_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2017.09.014","article-title":"A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma","volume":"1065\u20131066","author":"Lefeuvre","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.jpba.2022.115167_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00216-019-02285-0","article-title":"A 2D HPLC-MS\/MS method for several antibiotics in blood plasma, plasma water, and diverse tissue samples","volume":"412","author":"Rehm","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"issue":"12","key":"10.1016\/j.jpba.2022.115167_bib30","article-title":"Quantification of 15 antibiotics widely used in the critical care unit with a LC-MS\/MS system: an easy method to perform a daily therapeutic drug monitoring","volume":"14","author":"Feliu","year":"2021","journal-title":"Pharmers"},{"key":"10.1016\/j.jpba.2022.115167_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113899","article-title":"Development and validation of a simple and sensitive LC-MS\/MS method for quantification of ampicillin and sulbactam in human plasma and its application to a clinical pharmacokinetic study","volume":"196","author":"Nalbant","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2022.115167_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bcp.12232","article-title":"Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment","volume":"77","author":"Soto","year":"2014","journal-title":"Br. J. Clin. Pharm."},{"issue":"18","key":"10.1016\/j.jpba.2022.115167_bib33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4155\/bio.15.143","article-title":"An UHPLC-MS\/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma and urine","volume":"7","author":"Parker","year":"2015","journal-title":"Bioanalysis"},{"issue":"30","key":"10.1016\/j.jpba.2022.115167_bib34","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.jchromb.2010.09.021","article-title":"Liquid chromatography\/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study","volume":"878","author":"Zhou","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jpba.2022.115167_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpba.2006.08.010","article-title":"Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC\/MS\/MS method for the determination of carvedilol enantiomers in human plasma","volume":"43","author":"Wang","year":"2007","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852200588X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852200588X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:22:56Z","timestamp":1760001776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852200588X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"alternative-id":["S073170852200588X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115167","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A liquid chromatography-tandem mass spectrometry method for the quantification of ampicillin\/sulbactam and clindamycin in jawbone, plasma, and platelet-rich fibrin: Application to patients with osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115167"}}